CCL2 and breast carcinoma: Studies have revealed that CCL2 improves the survival, motion ability, and migration of mammary carcinoma cell lines 4T1, MCF-7, PyVmT, and MDA-MB-231 by activating phosphorylation of Smad3 and p42/44 MAPK [37].